Cohorts description
UK Young Lacunar Stroke DNA Study (DNA Lacunar) DNA Lacunar is a multicentre cohort study, which constitutes a large DNA resource of young patients with well phenotyped lacunar stroke and stroke-free community controls. Between 2005 and 2012, 1030 white patients of European ancestry with lacunar stroke, aged < 70 years, were recruited from 72 specialist stroke centres throughout the UK. All patients underwent brain MRI, imaging of the carotid arteries and ECG. Echocardiography was performed when appropriate. All MRI's and clinical histories were reviewed centrally by one experienced stroke physician. 970 Unrelated Caucasian controls, free of clinical cerebrovascular disease, were obtained by random sampling from general practice lists from the same geographical location as the patients. Sampling was stratified for age and sex.
Wellcome Trust Case-Control Consortium 2 (WTCCC2)
The WTCCC2 samples were genotyped as part of the WTCCC 2 ischemic stroke study. Stroke cases were recruited from three centres in the UK (St. George's University London, Oxford and Edinburgh) and one centre in Germany, University and Klinikum Großhadern, Ludwig-Maximilians-University, Munich WTCCC2-UK: The St George's Stroke Study consecutively recruited ischemic stroke patients attending cerebrovascular services in London between 1995 and 2008. All patients had clinically relevant diagnostic workup performed, including brain imaging with computed tomography (CT) and/or magnetic resonance imaging (MRI) as well as ancillary diagnostic investigations including duplex ultrasonography of the carotid and vertebral arteries, echocardiography, Holter monitoring, magnetic resonance angiography (MRA), CT-angiography (CTA) and blood tests. The Oxford Vascular Study recruited patients with acute ischemic stroke or transient ischemic attack (TIA) with evidence of infarction on brain imaging between 2002 and 2008 as part of a population-based stud. All cases were phenotyped by one experienced stroke neurologist with review of original imaging. The Edinburgh Stroke Study prospectively recruited consecutive stroke inpatients and outpatients between 2002 and 2005. An experienced stroke physician assessed each patient as soon as possible after the stroke, prospectively recording demographic and clinical details, including vascular risk factors and results of brain imaging and other investigations WTCCC2-Germany: The Munich study recruited consecutively between 2002 and 2008, from a single Stroke Unit with a high rate of MR imaging (>80%) (n=1383). All subjects were over 18 years of age, of self-reported European ancestry and with a diagnosis of ischemic stroke classified according to TOAST by an experienced neurologist or stroke physician. All patients had brain imaging as well as ancillary diagnostic investigations where clinically relevant. Controls for the UK samples were drawn from shared WTCCC controls obtained from the 1958 Birth Cohort. This is a prospectively collected cohort of individuals born in 1958 (http://www.b58cgene.sgul.ac.uk/), and ascertained as part of the national child development study (http://www.cls.ioe.ac.uk/studies.asp?section=000100020003). Data from this cohort are available as a common control set for a number of genetic and epidemiological studies. For the German samples controls were Caucasians of German origin participating into the population KORAgen study (www.gsf.de/kora/en/english.html). This survey represents a gender-and age stratified random sample of all German residents of the Augsburg area and consists of individuals 25 to 74 years of age, with about 300 subjects for each 10-year increment. All controls were free of a history of stroke or transient ischemic attack.
Leuven Stroke Study
Patients with cerebral ischemia, defined as a clinical stroke with imaging confirmation or a TIA with a new ischemic lesion on diffusion weighted MRI, who were admitted to the Stroke Unit of the University Hospitals in Leuven were enrolled. All patients underwent brain imaging and a standardized protocol including carotid ultrasound or CT angiography and cardiac examination (echocardiography and Holter monitoring) in all patients. Control individuals were selected from the same population and were either spouses of patients with multiple sclerosis, amyotrophic lateral sclerosis or stroke or healthy community dwelling subjects partially from the Leuven University Gerontology Database. Controls either confirmed they never had a stroke or TIA or responded negative to any item of the Verification of Stroke Free Status questionnaire.
Besta Stroke Study (Milano)
This study includes consecutive Italian patients referred to Besta Institute from 2000 to 2009 with stroke and included in the Besta Cerebrovascular Diseases Registry (CEDIR). Ischemic stroke cases, first ever or recurrent, confirmed on brain imaging, were selected for this study. An experienced stroke neurologist assessed all cases.
St Georges University of London (SGUL)
This study recruited patients attending cerebrovascular services at St. George's Hospital, London between 2007-2011. All patients had clinically relevant diagnostic workup performed, including brain imaging with magnetic resonance imaging (MRI) as well as ancillary diagnostic investigations including duplex ultrasonography of the carotid and vertebral arteries, echocardiography, Holter monitoring, magnetic resonance angiography (MRA), CT-angiography (CTA) and blood tests GENESIS This study recruited patients attending cerebrovascular services at St. George's Hospital, London between 2011-2013. All patients had clinically relevant diagnostic workup performed, including brain imaging with magnetic resonance imaging (MRI) as well as ancillary diagnostic investigations including duplex ultrasonography of the carotid and vertebral arteries, echocardiography, Holter monitoring, magnetic resonance angiography (MRA), CT-angiography (CTA) and blood tests
Massachusetts General Hospital (MGH)
Cases presenting with ischemic stroke and admitted to the Massachusetts General Hospital (MGH) Stroke Unit through the Emergency Department, or evaluated in the MGH Neurology outpatient clinics, as well as on the inpatient Medical and Vascular Surgical services from January 2003 to July 2008. Ischemic stroke was defined as either (1) a radiographically proven (head CT or MRI) infarct associated with the appropriate clinical stroke syndrome, or (2) a fixed neurological deficit persisting more than 24 hours, consistent with a vascular pattern of involvement and without radiographic evidence of demyelinating or other nonvascular disease. All subjects were evaluated by a neurologist upon presentation and clinical and laboratory data were collected during the admission for qualifying ischemic stroke event. All patients had acute brain imaging as well as ancillary diagnostic investigations: cervical and intracranial vessel imaging using CT or MR angiography (75%), cervical ultrasound (24%), echocardiography (86%), and Holter monitoring (16%).
Australian Stroke Genetics Collaborative (ASGC)
Stroke cases comprised European-ancestry patients admitted to four clinical centres across Australia (The Neurosciences Department at Gosford Hospital, Gosford, New South Wales (NSW); the Neurology Department at John Hunter Hospital, Newcastle, NSW; The Queen Elizabeth Hospital, Adelaide; and the Royal Perth Hospital, Perth) between 2003 and 2008. Stroke was defined by WHO criteria as a sudden focal neurologic deficit of vascular origin, lasting more than 24 hours and confirmed by brain imaging. Other investigative tests such as electrocardiogram, carotid Doppler and trans-oesophageal echocardiogram were conducted to define stroke aetiology as clinically appropriate.
Ischemic Stroke Genetics Study (ISGS)
Ischemic Stroke Genetics Study (ISGS) was a 5-center, prospective, case-control study of first-ever ischemic stroke cases. All affected individuals had WHO-defined stroke confirmed by a study neurologist to be ischemic on the basis of head CT or brain MRI. Peripheral blood DNA samples were collected between May 2003 and September 2008.
Sibling with Ischaemic Stroke Study (SWISS)
This is a prospective, multicentre study of sibling pairs with first-ever or recurrent ischemic stroke. Probands were recruited from 70 clinical centres across the US and Canada. Ischemic stroke affected and unaffected siblings were recruited primarily using proband-initiated contact. All affected individuals had WHO-defined stroke confirmed by a study neurologist to be ischemic on the basis of brain imaging. Peripheral blood DNA samples were collected between October 2000 and December 2009. Power calculations were conducted using the Genetic Power Calculator 2 for a case-control study of discrete traits under an additive disease risk model and a disease prevalence of 0.2% for lacunar stroke. 
